annual cash & cash equivalents:
$60.47M+$19.18M(+46.46%)Summary
- As of today (May 29, 2025), SBRA annual cash & cash equivalents is $60.47 million, with the most recent change of +$19.18 million (+46.46%) on December 31, 2024.
- During the last 3 years, SBRA annual cash & cash equivalents has fallen by -$51.53 million (-46.01%).
- SBRA annual cash & cash equivalents is now -88.34% below its all-time high of $518.63 million, reached on December 31, 2017.
Performance
SBRA Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$22.65M-$37.81M(-62.54%)Summary
- As of today (May 29, 2025), SBRA quarterly cash & cash equivalents is $22.65 million, with the most recent change of -$37.81 million (-62.54%) on March 31, 2025.
- Over the past year, SBRA quarterly cash & cash equivalents has dropped by -$37.27 million (-62.20%).
- SBRA quarterly cash & cash equivalents is now -95.85% below its all-time high of $546.34 million, reached on September 30, 2021.
Performance
SBRA quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SBRA Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +46.5% | -62.2% |
| 3 y3 years | -46.0% | -8.8% |
| 5 y5 years | +54.7% | -58.1% |
SBRA Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -46.0% | +46.5% | -66.3% | at low |
| 5 y | 5-year | -46.0% | +54.7% | -95.8% | at low |
| alltime | all time | -88.3% | +1303.6% | -95.8% | +746.8% |
SBRA Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $22.65M(-62.5%) |
| Dec 2024 | $60.47M(+46.5%) | $60.47M(-4.0%) |
| Sep 2024 | - | $63.00M(+73.1%) |
| Jun 2024 | - | $36.40M(-39.3%) |
| Mar 2024 | - | $59.93M(+45.2%) |
| Dec 2023 | $41.28M(-16.3%) | $41.28M(+24.1%) |
| Sep 2023 | - | $33.26M(+22.1%) |
| Jun 2023 | - | $27.23M(-18.8%) |
| Mar 2023 | - | $33.53M(-32.0%) |
| Dec 2022 | $49.31M(-56.0%) | $49.31M(+87.6%) |
| Sep 2022 | - | $26.29M(-60.9%) |
| Jun 2022 | - | $67.15M(+170.4%) |
| Mar 2022 | - | $24.84M(-77.8%) |
| Dec 2021 | $112.00M(+89.6%) | $112.00M(-79.5%) |
| Sep 2021 | - | $546.34M(+687.8%) |
| Jun 2021 | - | $69.35M(+178.7%) |
| Mar 2021 | - | $24.88M(-57.9%) |
| Dec 2020 | $59.08M(+51.1%) | $59.08M(+68.6%) |
| Sep 2020 | - | $35.03M(+24.0%) |
| Jun 2020 | - | $28.25M(-47.7%) |
| Mar 2020 | - | $54.05M(+38.2%) |
| Dec 2019 | $39.10M(-22.2%) | $39.10M(+32.8%) |
| Sep 2019 | - | $29.43M(-38.2%) |
| Jun 2019 | - | $47.59M(+108.1%) |
| Mar 2019 | - | $22.87M(-54.5%) |
| Dec 2018 | $50.23M | $50.23M(+38.2%) |
| Sep 2018 | - | $36.35M(-6.3%) |
| Jun 2018 | - | $38.81M(-16.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2018 | - | $46.35M(-91.1%) |
| Dec 2017 | $518.63M(+1920.9%) | $518.63M(+1579.9%) |
| Sep 2017 | - | $30.87M(+133.3%) |
| Jun 2017 | - | $13.23M(+3.3%) |
| Mar 2017 | - | $12.81M(-50.1%) |
| Dec 2016 | $25.66M(+245.2%) | $25.66M(+30.4%) |
| Sep 2016 | - | $19.67M(-81.1%) |
| Jun 2016 | - | $103.87M(+1037.3%) |
| Mar 2016 | - | $9.13M(+22.9%) |
| Dec 2015 | $7.43M(-88.0%) | $7.43M(-76.4%) |
| Sep 2015 | - | $31.47M(+420.9%) |
| Jun 2015 | - | $6.04M(+44.9%) |
| Mar 2015 | - | $4.17M(-93.3%) |
| Dec 2014 | $61.79M(+1334.4%) | $61.79M(+142.5%) |
| Sep 2014 | - | $25.48M(+68.9%) |
| Jun 2014 | - | $15.09M(+252.0%) |
| Mar 2014 | - | $4.29M(-0.5%) |
| Dec 2013 | $4.31M(-74.8%) | $4.31M(-95.5%) |
| Sep 2013 | - | $96.64M(+4.2%) |
| Jun 2013 | - | $92.77M(+73.2%) |
| Mar 2013 | - | $53.56M(+213.2%) |
| Dec 2012 | $17.10M(-59.5%) | $17.10M(-43.9%) |
| Sep 2012 | - | $30.48M(+880.0%) |
| Jun 2012 | - | $3.11M(+16.3%) |
| Mar 2012 | - | $2.67M(-93.7%) |
| Dec 2011 | $42.25M | $42.25M(-25.1%) |
| Sep 2011 | - | $56.42M(+1533.4%) |
| Jun 2011 | - | $3.45M(-95.7%) |
| Mar 2011 | - | $80.21M |
FAQ
- What is Sabra Health Care REIT annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Sabra Health Care REIT?
- What is Sabra Health Care REIT annual cash & cash equivalents year-on-year change?
- What is Sabra Health Care REIT quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Sabra Health Care REIT?
- What is Sabra Health Care REIT quarterly cash & cash equivalents year-on-year change?
What is Sabra Health Care REIT annual cash & cash equivalents?
The current annual cash & cash equivalents of SBRA is $60.47M
What is the all time high annual cash & cash equivalents for Sabra Health Care REIT?
Sabra Health Care REIT all-time high annual cash & cash equivalents is $518.63M
What is Sabra Health Care REIT annual cash & cash equivalents year-on-year change?
Over the past year, SBRA annual cash & cash equivalents has changed by +$19.18M (+46.46%)
What is Sabra Health Care REIT quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of SBRA is $22.65M
What is the all time high quarterly cash & cash equivalents for Sabra Health Care REIT?
Sabra Health Care REIT all-time high quarterly cash & cash equivalents is $546.34M
What is Sabra Health Care REIT quarterly cash & cash equivalents year-on-year change?
Over the past year, SBRA quarterly cash & cash equivalents has changed by -$37.27M (-62.20%)